article thumbnail

Bicuspid Anatomy: Wrench Thrown in TAVR for Younger, Low-Risk Patients?

Med Page Today

(MedPage Today) -- PARIS -- Patients with questionable suitability for transcatheter aortic valve replacement (TAVR) in fact fared worse in the short term after the catheter-based procedure than after surgery, the NOTION-2 randomized trial showed.

TAVR 52
article thumbnail

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

DAIC

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.

TAVR 111
article thumbnail

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

DAIC

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR 111
article thumbnail

What Is TAVR? A Closer Look at Transcatheter Aortic Valve Replacement

AMS Cardiology

If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. If you’re wondering “ What is TAVR ?” A Minimally Invasive Approach to Aortic Valve Replacement With TAVR TAVR offers a groundbreaking alternative to traditional surgery. Who Is a Candidate for TAVR?

article thumbnail

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

DAIC

The SMART trial is the first randomized head-to-head comparison of the two most widely used TAVR devices—the supra-annular self-expanding Evolut PRO/PRO+/FX and the balloon-expandable SAPIEN 3/3 Ultra. The trial enrolled 716 patients who underwent TAVR at 83 international sites in North America, Europe and the Middle East.

TAVR 59
article thumbnail

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Circulation: Cardiovascular Interventions

BACKGROUND:Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients.

TAVR 40
article thumbnail

Association of Bovine Arch Anatomy With Incident Stroke After Transcatheter Aortic Valve Replacement

Journal of the American Heart Association

BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). This study aimed to identify the aortic anatomic correlates in patients after TAVR stroke.Methods and ResultsThis is a single‐center, retrospective study of patients who underwent TAVR at the Mayo Clinic between 2012 and 2022.